Such bioinformatic analysis of quantitative phosphoproteomics data from NSCLC clinical samples and cell lines also supported the oncogenic effect of syntenin-1 phosphorylation by TBK1. The gene discussed is TBK1; the disease is non-small cell lung carcinoma.